Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?

8:26
 
Share
 

Manage episode 266653556 series 2740117
By MasterMedFacts LLC, Dr RR Baliga, MD, and MBA. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

References

Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343

Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion

234 episodes